Hiroo Tani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hiroo Tani has a total of 102 co-authors. Here are the top co-authors by number of shared publications:
- Adrian Gervais
St. Giles Laboratory of Human Genetics of Infectious Diseases, The Rockefeller University
1 shared publication - Aissata Sacko-Sow
Jean Verdier Hospital, AP-HP 35 Department of Pediatrics Bondy
1 shared publication Akira Kato
Suzugamine Facility for Persons with Severe Motor and Intellectual Disabilities, Hiroshima, Japan
1 shared publication- Alessandra Pescatore
International Institute of Genetics and Biophysics-CNR
1 shared publication - Amyrath Geraldo
Laboratory of Human Genetics of Infectious Diseases, https://ror.org/02vjkv261Necker Branch, INSERM U1163 Necker Hospital for Sick Children, Paris, France
1 shared publication - Ana Elisa Kiszewski
Universidade de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, RS, Brazil
1 shared publication
Latest Publications
- Open Access
- 1 October 2024
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 221 (11)
Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseases
Human inborn errors of thymic T cell tolerance underlie the production of autoantibodies (auto-Abs) neutralizing type I IFNs, which predispose to severe viral diseases. We analyze 131 female patients with X-linked dominant incontinentia pigmenti (IP), heterozygous for loss-of-function (LOF) NEMO variants, from 99 kindreds in 10 countries. Forty-seven of these patients (36%) have auto-Abs neutralizing IFN-α and/or IFN-ω, a proportion 23 times higher than that for age-matched female controls. This proportion remains stable from the age of 6 years onward. On imaging, female patients with IP have a small, abnormally structured thymus. Auto-Abs against type I IFNs confer a predisposition to life-threatening viral diseases. By contrast, patients with IP lacking auto-Abs against type I IFNs are at no particular risk of viral disease. These results suggest that IP accelerates thymic involution, thereby underlying the production of auto-Abs neutralizing type I IFNs in at least a third of female patients with IP, predisposing them to life-threatening viral diseases.
- 1 October 2024
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 221 (11)
Open AccessIncontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseases
Human inborn errors of thymic T cell tolerance underlie the production of autoantibodies (auto-Abs) neutralizing type I IFNs, which predispose to severe viral diseases. We analyze 131 female patients with X-linked dominant incontinentia pigmenti (IP), heterozygous for loss-of-function (LOF) NEMO variants, from 99 kindreds in 10 countries. Forty-seven of these patients (36%) have auto-Abs neutralizing IFN-α and/or IFN-ω, a proportion 23 times higher than that for age-matched female controls. This proportion remains stable from the age of 6 years onward. On imaging, female patients with IP have a small, abnormally structured thymus. Auto-Abs against type I IFNs confer a predisposition to life-threatening viral diseases. By contrast, patients with IP lacking auto-Abs against type I IFNs are at no particular risk of viral disease. These results suggest that IP accelerates thymic involution, thereby underlying the production of auto-Abs neutralizing type I IFNs in at least a third of female patients with IP, predisposing them to life-threatening viral diseases.
- 2 April 2019
- Published by Georg Thieme Verlag KG in Neuropediatrics
- Vol. 50 (03) , 160-163
High Incidence of Renal Stones in Severely Disabled Children with Epilepsy Treated with Topiramate
Purpose This study was aimed to assess the accurate incidence of renal stones in severely disabled children treated with topiramate (TPM). Method We reviewed the medical records of severely disabled children with epilepsy under 15 years old who underwent radiological examinations to investigate urinary stones. The study enrolled 26 patients who were divided into two groups. One group had been treated with TPM for at least 1 year and the other had not been treated with TPM, zonisamide, acetazolamide, or other diuretic drugs. We collected parameters from the medical records and compared the groups. Results All participants were evaluated radiologically, with computed tomography (CT) in two patients, ultrasonography in 22 patients, and both in two. No patient had any morphological abnormality of the kidneys and history of urinary tract infection. There were no significant differences in sex, age, body weight, or feeding manner between the groups, while the incidence of renal stones or calcifications was significantly higher in the TPM-treated group (60 vs. 0%; p = 0.00241). Conclusion There is a high incidence of renal stone formation in severely disabled children treated with TPM.
- 2 April 2019
- Published by Georg Thieme Verlag KG in Neuropediatrics
- Vol. 50 (03) , 160-163
High Incidence of Renal Stones in Severely Disabled Children with Epilepsy Treated with Topiramate
Purpose This study was aimed to assess the accurate incidence of renal stones in severely disabled children treated with topiramate (TPM). Method We reviewed the medical records of severely disabled children with epilepsy under 15 years old who underwent radiological examinations to investigate urinary stones. The study enrolled 26 patients who were divided into two groups. One group had been treated with TPM for at least 1 year and the other had not been treated with TPM, zonisamide, acetazolamide, or other diuretic drugs. We collected parameters from the medical records and compared the groups. Results All participants were evaluated radiologically, with computed tomography (CT) in two patients, ultrasonography in 22 patients, and both in two. No patient had any morphological abnormality of the kidneys and history of urinary tract infection. There were no significant differences in sex, age, body weight, or feeding manner between the groups, while the incidence of renal stones or calcifications was significantly higher in the TPM-treated group (60 vs. 0%; p = 0.00241). Conclusion There is a high incidence of renal stone formation in severely disabled children treated with TPM.